HPK1-IN-71
HPK1-IN-71 is a potent and selective HPK1 inhibitor with an IC50 of 26.3 nM. HPK1-IN-71 can inhibit the phosphorylation of SLP76, promote the secretion of IL-2 and show high selectivity for other kinases and immune-targeting kinases. HPK1-IN-71 can be used in colon cancer research.
For research use only. We do not sell to patients.
- Formula: C26H25FN8O
- Molecular Weight:484.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All MAP4K Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
HPK1 26.3 nM (IC50) |
IL-2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Jurkat | IC50 |
63.00 μM
|
Does not affect cell viability.
Does not affect cell viability.
|
42335717 |
In Vitro
HPK1-IN-71 (compound D5) (0.11-1 μM; pretreatment for 30min + co-incubation with CD3/CD28 for 24h) leads to a modest yet statistically significant enhancement of IL-2 secretion at 0.33 μM, whereas the IL-2 stimulatory effect is diminished at 1 μM in primary mouse T cells[1].
HPK1-IN-71 (0-10 μM pretreatment for 2h + co-incubation with anti-CD3/CD28 antibodies for 10 min) leads to aconcentration-dependent reduction in SLP76 phosphorylation in Jurkat cells with significant inhibition at 1 μM and 10 μM[1].
HPK1-IN-71 (0-100 μM; 72 h) displays low cytotoxicity in Jurkat cells IC50= 63.00 μM)[1].
HPK1-IN-71 (1 μM; pretreatment for 60min + co-incubation with ADP-Glo™ reagent for 40min) only inhibits CDK2 and MST1 with > 80% inhibition, while exhibiting 50%-80% inhibition against just six other kinases. HPK1-IN-71 demonstrates high selectivity over LCK, IKKα and TAK1, all of which are directly involved in TCR signaling. HPK1-IN-71 displays moderate inhibition of GCK (MAP4K2), KHS (MAP4K5) and GLK (MAP4K3) with all inhibition rates below 80%. HPK1-IN-71 demonstrates a high degree of selectivity towards HGK (MAP4K4), MINK (MAP4K6) and all tested immune-related tyrosine kinases [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Primary mouse T cells
-
Concentration:0.11 μM, 0.33 μM, 1 μM
-
Incubation Time:pretreatment for 30min + co-incubation with CD3/CD28 for 24h
-
Result:Promoted IL-2 secretion from primary mouse T cells at a concentration of 0.33 μM.
-
Cell Line:Jurkat cells
-
Concentration:0.01 μM, 0.1 μM, 1 μM, 10μM
-
Incubation Time:pretreatment for 2h + co-incubation with anti-CD3/CD28 antibodies for 10 min
-
Result:Significantly downregulated SLP76 phosphorylation levels in Jurkat cells.
-
Cell Line:Jurkat cells
-
Concentration:3.13 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, 100 μM
-
Incubation Time:72 h
-
Result:Did not affect cell viability in Jurkat cells.
Parmacokinetics
| Species | Dose | Route | T1/2 | Tmax | Cmax | AUC0-t | AUC0-inf | MRT |
|---|---|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | i.p. | 2.8 h | 0.2 h | 3289.0 ng/mL | 3739.0 ng·h/mL | 3867.3 ng·h/mL | 2.8 h |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice (4-6 weeks old) were inoculated subcutaneously with CT26 cells (4 × 105 cells per mouse)[1].
-
Dosage:10 or 20 mg/kg
-
Administration:i.p.; twice daily; for 13 days
-
Result:Showedminimal antitumor efficacy at the dose of 10 mg/kg.
Showed significant antitumor potency with TGI of 37.2% at the dose of 20 mg/kg.
Did not change the mouse body weight.
Chemical Information
-
Molecular Weight 484.53
-
Formula C26H25FN8O
-
SMILES
COC1=C(C2=CC3=C(NN=C3NC4=C5C=CC=CC5=NC(N6CCC(N)CC6)=N4)C=N2)C(F)=CC=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)